Omega Healthcare Investors (NYSE:OHI) Sets New 1-Year High – Here’s Why

Omega Healthcare Investors, Inc. (NYSE:OHI) reached a new 52-week high during trading on Tuesday . The stock traded as high as $44.73 and last traded at $44.4950, with a volume of 102952 shares changing hands. The stock had previously closed at $44.18.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on OHI. Cantor Fitzgerald began coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 target price for the company. Weiss Ratings reiterated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Mizuho raised their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. UBS Group assumed coverage on Omega Healthcare Investors in a research note on Tuesday. They set a “buy” rating and a $50.00 price objective on the stock. Finally, Citigroup restated a “buy” rating and issued a $50.00 target price (up previously from $45.00) on shares of Omega Healthcare Investors in a research note on Wednesday, November 12th. Seven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $45.89.

Omega Healthcare Investors Trading Up 0.9%

The stock has a market cap of $13.34 billion, a PE ratio of 27.86, a PEG ratio of 1.85 and a beta of 0.69. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a fifty day simple moving average of $41.73 and a two-hundred day simple moving average of $39.61.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $311.59 million for the quarter, compared to analysts’ expectations of $262.48 million. During the same period in the prior year, the business earned $0.71 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. As a group, equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 3rd were given a $0.67 dividend. The ex-dividend date was Monday, November 3rd. This represents a $2.68 annualized dividend and a yield of 5.9%. Omega Healthcare Investors’s payout ratio is 149.72%.

Insiders Place Their Bets

In other news, CIO Vikas Gupta purchased 11,500 shares of the stock in a transaction on Thursday, November 6th. The shares were acquired at an average price of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the transaction, the executive directly owned 13,773 shares of the company’s stock, valued at approximately $591,825.81. This trade represents a 505.94% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO C Taylor Pickett purchased 20,000 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were purchased at an average cost of $43.14 per share, with a total value of $862,800.00. Following the purchase, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $862,800. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of OHI. Norges Bank purchased a new stake in Omega Healthcare Investors during the second quarter valued at about $121,800,000. Invesco Ltd. lifted its stake in shares of Omega Healthcare Investors by 101.7% in the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock valued at $208,775,000 after acquiring an additional 2,493,877 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock valued at $108,989,000 after acquiring an additional 2,322,878 shares during the period. Hudson Bay Capital Management LP bought a new position in Omega Healthcare Investors during the 2nd quarter worth approximately $71,312,000. Finally, JPMorgan Chase & Co. increased its stake in Omega Healthcare Investors by 77.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock worth $144,278,000 after purchasing an additional 1,496,059 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.